Robuta

https://www.mayoclinic.org/drugs-supplements/insulin-lispro-intravenous-route-subcutaneous-route/description/drg-20064334
insulin lisprointravenous routeside effectssubcutaneousdosage
https://www.expertmarketresearch.com/reports/asia-pacific-biosimilar-insulin-glargine-and-lispro-market
APAC biosimilar insulin market grows with global rise. Global market to hit USD 9272.31 Million by 2035 from USD 2436.27 Million in 2025 at 14.30% CAGR.
biosimilar insulinapacglarginelispromarket